Loading...

Abbott Laboratories (NYSE:ABT)

106.97 USD -2.11 USD ( -1.93% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

Intrinsic Value

The intrinsic value of one ABT stock under the Base Case scenario is 95.84 USD. Compared to the current market price of 106.97 USD, Abbott Laboratories is Overvalued by 10%.

The Intrinsic Value is calculated as the average of the two valuation methods:

Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

ABT Profitability Score
Profitability Due Diligence

Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
Positive ROIC
Positive Net Income
62/100
Profitability
Score

Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

ABT Solvency Score
Solvency Due Diligence

Abbott Laboratories's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Short-Term Liabilities
Long-Term Liabilities
Low D/E
75/100
Solvency
Score

Abbott Laboratories's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall Street
Price Targets

ABT Price Targets
Price Targets made by Wall Street

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

12-month price targets for ABT stock made by Wall Street professionals. The average price target is 142.08 USD with a low forecast of 112.11 USD and a high forecast of 166.43 USD.

Lowest
Price Target
112.11 USD
5% Upside
Average
Price Target
142.08 USD
33% Upside
Highest
Price Target
166.43 USD
56% Upside
View Analyst Estimates
View Analyst Estimates

Insider Trading

ABT Insider Trading
Buy and sell transactions by insiders

Abbott Laboratories insiders have only sold shares in the past 3 months.

During the last 3 months Abbott Laboratories insiders have not bought any shares, and sold 8.4M USD worth of shares. The last transaction was made on May 4, 2022 by Randel William Woodgrift, who sold 2.7M USD worth of ABT shares.

Sold
0-3
months
8.4M USD
2
3-6
months
926k USD
6
6-9
months
10.2M USD
4
9-12
months
5M USD
3
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative amount
Period Sold Bought Net
3 Months
8.4M USD
N/A
-8.4M
6 Months
9.3M USD
N/A
-9.3M
9 Months
19.5M USD
N/A
-19.5M
12 Months
24.5M USD
N/A
-24.5M
Date Value Insider Name Amount Avg Price
2022-05-04
Sell
2 712 000 USD
Randel William Woodgrift -24 000 113 USD
2022-05-03
Sell
5 661 000 USD
Daniel J Starks -50 000 113.22 USD
2022-03-08
Sell
468 000 USD
Michael D Dale -4 000 117 USD
2022-03-01
Sell
113 848 USD
Randel William Woodgrift -964 118.1 USD
2022-03-01
Sell
53 867 USD
Andrea F Wainer -456 118.13 USD
2022-02-24
Sell
187 902 USD
Nancy Mckinstry -1 614 116.42 USD
2022-02-22
Sell
55 112 USD
Julie L Tyler -462 119.29 USD
2022-02-22
Sell
47 724 USD
Mary K Moreland -400 119.31 USD
2021-12-27
Sell
427 500 USD
Andrea F Wainer -3 000 142.5 USD
2021-12-23
Sell
658 000 USD
Sammy Karam -4 700 14 USD
2021-12-23
Sell
1 820 000 USD
Andrea F Wainer -13 000 14 USD
2021-12-17
Sell
1 373 750 USD
Louis H Morrone -9 988 137.54 USD
2021-12-17
Sell
1 031 550 USD
Andrea F Wainer -7 500 137.54 USD
2021-12-13
Sell
1 957 500 USD
Andrea F Wainer -14 500 135 USD
2021-12-06
Sell
1 308 659 USD
Louis H Morrone -9 989 131.01 USD
2021-12-06
Sell
596 250 USD
Andrea F Wainer -4 500 132.5 USD
2021-10-25
Sell
1 011 920 USD
Philip P Boudreau -8 000 126.49 USD
2021-09-08
Sell
2 969 182 USD
Michael J Pederson -23 008 129.05 USD
2021-09-03
Sell
819 150 USD
Randel William Woodgrift -6 350 129 USD
2021-09-02
Sell
1 211 250 USD
Andrea F Wainer -9 500 127.5 USD
Why is insider trading important?

Competitors

Competitors Valuation
Abbott Laboratories Competitors

Shareholder Return

ABT Price
Abbott Laboratories

1M 1M
-9%
6M 6M
-23%
1Y 1Y
-6%
3Y 3Y
+33%
5Y 5Y
+140%
Annual Price Range
106.97
52w Low
102.07
52w High
140.4
Price Metrics
Average Annual Return 24.39%
Standard Deviation of Annual Returns 3.5%
Max Drawdown -27%

Company Profile

Abbott Laboratories

Country

United States of America

Industry

Health Care

Market Cap

188B USD

Dividend Yield

1.87%

Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 113,000 full-time employees. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Contact

ILLINOIS
ABBOTT PARK
100 Abbott Park Rd
+12246676100.0
https://www.abbott.com/

IPO

1937-03-01

Employees

113 000

Officers

Chairman, Pres & CEO
Mr. Robert B. Ford
Exec. VP of Fin. & CFO
Mr. Robert E. Funck Jr.
Exec. VP, Gen. Counsel & Sec.
Mr. Hubert L. Allen
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
Mr. Daniel Gesua Sive Salvadori
Exec. VP of Rapid & Molecular Diagnostics
Ms. Andrea F. Wainer
VP of Investor Relations, Licensing & Acquisitions
Mr. Scott Michael Leinenweber
Show More
VP and Chief Ethics & Compliance Officer
James E. Young
VP of Public Affairs & Corp. Marketing
Ms. Melissa Brotz
Sr. VP and Chief Marketing & External Affairs Officer
Ms. Elaine R. Leavenworth
Exec. VP of HR
Ms. Mary K. Moreland
Show Less

See Also

Similar Stocks

ABT Stock FAQ

What is the Intrinsic Value of one ABT stock?

The intrinsic value of one ABT stock under the Base Case scenario is 95.84 USD.

Is ABT stock undervalued or overvalued?

Compared to the current market price of 106.97 USD, Abbott Laboratories is Overvalued by 10%.